Terns Pharmaceuticals, Inc.TERNNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +8.79% | +26.14% | +22.95% | +22.99% | +17.84% |
| Weighted Average Shares Diluted Growth | +8.79% | +26.14% | +22.95% | +22.99% | +17.84% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +39.22% | +35.53% | +37.50% | +38.78% | -20.25% |
| Book Value per Share Growth | +29.64% | +7.37% | +12.02% | +13.49% | -33.86% |
| Debt Growth | +69.48% | +123.38% | +189.23% | +355.02% | -21.15% |
| R&D Expense Growth | +2.28% | +3.12% | +0.72% | +10.90% | +31.30% |
| SG&A Expenses Growth | -46.77% | +20.40% | +26.94% | -2.16% | -20.17% |